HM1.AX

Hearts and Minds Investments Limited (HM1.AX) operates as an Australian listed investment company with a dual objective: to assemble a focused investment portfolio comprising the most compelling ideas from various fund managers, and simultaneously to contribute to Australian medical research initiatives. The company aims to offer shareholders an investment opportunity through a tightly concentrated portfolio of approximately 25 to 30 long positions in both Australian and international public equities, selected based on their highest conviction. Approximately 35% of its investment capital is allocated following the annual recommendations put forth by fund managers who speak at the Sohn Hearts & Minds Investment Leaders Conference, known as 'Conference Fund Managers'. The remaining 65% of the portfolio is guided by the strongest ideas from a group of six designated 'Core Fund Managers', which prominently include Caledonia (Private) Investments, Cooper Investors, and Magellan Asset Management, among others.